Skip to main content
. 2024 Sep 28;80(1):215–226. doi: 10.1111/all.16341

TABLE 1.

Diagnostic accuracy of BAT and Hoxb8 MAT.

Diagnostic test Optimal cut‐off AUROC Sensitivity Specificity PPV NPV
BAT 0.01 ng/ml (% CD63) 2.00 0.75 0.49 0.96 0.97 0.42
BAT 0.1 ng/ml (% CD63) 2.61 0.92 0.84 0.96 0.98 0.70
BAT 1 ng/ml (% CD63) 2.50 0.96 0.94 0.93 0.97 0.86
BAT 10 ng/ml (% CD63) 13.06 0.99 0.93 1.00 1.00 0.84
BAT 100 ng/ml (% CD63) 5.59 0.95 0.94 0.89 0.96 0.86
BAT 1000 ng/ml (% CD63) 17.10 0.84 0.84 0.74 0.89 0.65
Hoxb8 MAT 0.01 ng/ml (% CD107a) 1.02 0.52 0.49 0.63 0.77 0.33
Hoxb8 MAT 0.1 ng/ml (% CD107a) 1.13 0.52 0.71 0.44 0.77 0.38
Hoxb8 MAT 1 ng/ml (% CD107a) 1.24 0.73 0.72 0.63 0.83 0.47
Hoxb8 MAT 10 ng/ml (% CD107a) 1.98 0.92 0.80 0.96 0.98 0.65
Hoxb8 MAT 100 ng/ml (% CD107a) 2.58 0.97 0.91 0.96 0.98 0.81
Hoxb8 MAT 1000 ng/ml (%CD107a) 5.20 0.97 0.93 0.96 0.98 0.84